Grants for Public housing authorities - Health

The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated efficacy clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies. Information about the mission and research interests of the NINDS can be found at the NINDS website (http://www.ninds.nih.gov/)

This grant provides financial support for early-career researchers from diverse backgrounds to establish independent cancer research careers, particularly those planning to lead clinical trials.

This Funding Opportunity Announcement (FOA) is intended to provide an avenue for basic scientists, clinicians and clinical scientists to jointly initiate and conduct translational research projects which translate basic research findings into clinical tools for better human health. The scope of this FOA includes a range of activities to encourage translation of basic research findings which will impact the diagnosis, treatment and prevention of communication disorders. Connection to the clinical condition must be clearly established and the outcomes of the grant must have practical clinical impact.

The grant titled "The NINDS Human Cell and Data Repository" aims to support the maintenance and development of a repository for fibroblast and induced pluripotent stem cell lines, which will be distributed to researchers for advancing research in neurological disorders.

This grant provides funding to early career researchers proposing innovative studies on the genetics or epigenetics of substance use disorders, aiming to foster new insights and advancements in addiction research.

This funding opportunity announcement (FOA) invites applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS) by (1) developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice implementation to community health dissemination; (2) promoting partnerships and collaborations to facilitate and accelerate translational research projects locally, regionally, and nationally; (3) creating, providing, and disseminating innovative research programs and partnerships across institutions and communities to address health disparities and deliver the benefits of translational science to all; (4) creating and implementing scientific and operational innovations that increase the quality, safety, efficiency, effectiveness, and informativeness of clinical research; (5) providing a national resource for the rapid response to urgent public health needs; and (6) creating, providing, and disseminating CTS training for clinical research professionals of all disciplines on the research team. Along with this solicitation for the UM1 CTSA hub application, NCATS has published a separate, companion FOA that solicits applications for a required K12 Clinical Scientist Institutional Career Development Program Award (PAR-TR-22-career); both a UM1 hub application and the required K12 application must be submitted. If there is no companion K12 application submitted, the UM1 hub application will not be reviewed. However, if the UM1 application is funded and the companion K12 application is not funded, a resubmitted K12 application will be accepted. Additional companion FOAs solicit applications for optional training, career, and research ed

This funding opportunity provides financial support to various organizations, including governments and nonprofits, to raise awareness and improve understanding of Alpha-gal Syndrome across the United States, particularly in underserved areas.

This funding opportunity supports organizations in the southern United States to create integrated care models that improve HIV treatment and essential support services for women living with HIV.

This funding opportunity supports research projects aimed at reducing disparities in maternal health outcomes among vulnerable populations in the U.S. by investigating healthcare system and clinician factors.

This grant provides funding to organizations that promote vaccine confidence and health equity through partnerships and educational outreach, particularly targeting underserved populations across the United States.

This funding opportunity supports research institutions and organizations in developing innovative HIV vaccine candidates through preclinical and manufacturing processes, with a focus on partnerships and readiness for clinical trials.

This grant provides funding to support postdoctoral researchers from underrepresented backgrounds in neuroscience as they transition to independent faculty positions, promoting diversity in the field.

The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected that aging-adaptive diabetes technologies that address barriers for use among older adults with T1D will improve usability, adoption and adherence decreasing the risk of hypoglycemia (and hypoglycemia unawareness) while enhancing glycemic control, facilitating better diabetes management, and improving quality of life for these individuals and their caregivers.

The "E-Learning Collaborative for Integrated Violence Prevention" grant aims to fund the development and maintenance of an online learning community and platform, which will provide resources, technical assistance, and support to violence prevention practitioners, helping them to effectively implement and evaluate strategies to prevent various types of violence, while also promoting health equity.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development intends to publish a Notice of Funding Opportunity (NOFO) to invite applications to establish integrated and collaborative Stillbirth Research Centers, as part of a new Stillbirth Research Consortium. The Centers will support cutting-edge basic, translational, clinical, and/or data sciences research and generate knowledge to fuel advancement of stillbirth-relevant research in the United States, with a particular emphasis on approaches that utilize an equity lens to identify ways to decrease the incidence of stillbirth in vulnerable populations. A Data Coordinating Center (described in the companion announcement NOT-HD-24-010) will support the work of the research projects funded under the Stillbirth Research Consortium. This Notice is being provided to allow potential applicants additional time to develop meaningful collaborations, interdisciplinary teams, and responsive applications. International collaboration is encouraged and allowable. The NOFO is expected to be published in Summer 2024 with an expected application due date in Winter 2024. This NOFO will utilize the UG1 activity code. Details of the planned NOFO are provided below.

This funding opportunity supports independent research projects in health-related fields for a wide range of eligible applicants, including universities, nonprofits, and small businesses, without allowing clinical trials.

This funding opportunity supports researchers conducting mid-phase clinical trials on natural products, such as botanicals and dietary supplements, to determine optimal dosages and identify patient responses for future studies.

This grant provides funding for innovative early-stage cancer research projects that could lead to significant advancements in diagnosis, treatment, and prevention, targeting a wide range of eligible organizations including universities, nonprofits, and small businesses.

This funding opportunity provides up to $1 million to research centers focused on improving the diagnosis, treatment, and prevention of intellectual and developmental disabilities through collaborative and innovative research.

This funding opportunity supports research institutions and organizations in developing therapies and medical devices for various eye diseases, facilitating their transition from laboratory to clinical application.